Inogen, Inc. (NASDAQ:INGN) is on recovery track with -1.37% gain from a 1-year low price of $86.01. The company lost -3.61% to attain the price of $84.83 on 4/12/2019. Throughout the recent session, the prices were hovering between $83.56 and $89.74. These shares are 105.12% off its target price of $174 and the current market capitalization stands at $1.84B. The recent change has given its price a -24.44% deficit over SMA 50 and -70.52% deficit over its 52-week high. The stock witnessed -11.98% declines, -37.54% declines and -56.74% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found INGN’s volatility during a week at 4.68% and during a month it has been found around 4.03%.Inogen, Inc. (INGN) Top Holders
Institutional investors currently hold around $2 billion or 0% in INGN stock. Look at its top three institutional owners: Novo Holdings A/S owns $301.09 million in Inogen, Inc., which represents roughly 16.36% of the company’s market cap and approximately 15.04% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 2,233,303 shares of the stock are valued at $189.45 million. The third largest holder is Brown Capital Management Llc, which currently holds $181.22 million worth of this stock and that ownership represents nearly 9.85% of its market capitalization.
At the end of December reporting period, 158 institutional holders increased their position in Inogen, Inc. (NASDAQ:INGN) by some 5,309,175 shares, 166 decreased positions by 3,075,988 and 23 held positions by 15,209,195. That puts total institutional holdings at 23,594,358 shares, according to SEC filings. The stock grabbed 66 new institutional investments totaling 3,024,244 shares while 82 institutional investors sold out their entire positions totaling 1,191,571 shares.Inogen, Inc. (NASDAQ:INGN) Insider Trades
Multiple company employees have indulged in significant insider trading. Inogen, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Huggenberger Raymond has sold 8,500 shares of Inogen, Inc. (INGN) in the trading session dated Jan. 15, 2019. These shares are worth $1,162,885 and were traded at $136.81 each. The SEC filing shows that Huggenberger Raymond performed a sale of 8,500 shares. The Director disposed these shares by way of transaction on Dec. 14, 2018. The company’s shares were given away at $130.45 per share worth to an income of some $1,108,825 to the account of Huggenberger Raymond.
Director, Huggenberger Raymond, sold 9,569 common shares of Inogen, Inc. (INGN) in the open market. In a transaction dated Nov. 15, 2018, the shares were put up for sale at an average price of $129.3, raking in a sum of $1,237,272. After this sale, 7,797 common shares of INGN are directly owned by the insider, with total stake valued at $661,420.
In the transaction dated Nov. 08, 2018, a great number of shares sold came courtesy the Director; McFarland Loren L disposed a total of 2,000 shares at an average price of $155.24, amounting to approximately $310,480. The insider now directly owns 989 shares worth $83,897.
Several analysts have released their opinion on Inogen, Inc. (NASDAQ:INGN), with 4 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.57 average brokerage recommendation [T1].